HR
LHDX

Howe & Rusling’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Howe & Rusling’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-200
Closed -$1K – 1050
2021
Q2 		$1K Buy
+200
New +$1.26K ﹤0.01% 927

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Howe & Rusling's LHDX Position: Q3 2021 in Review

Howe & Rusling sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2021, closing a stake of 200 shares — an estimated $1K sold.

Howe & Rusling first reported a position in LHDX in Q2 2021 and held it in 1 quarter. The position peaked at $1K in Q2 2021. 36 funds tracked by Wall St. Rank hold LHDX as of Q3 2021.

  • Howe & Rusling reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Howe & Rusling sold 200 Lucira Health, Inc. Common Stock shares in Q3 2021, an estimated $1K.
  • Howe & Rusling first reported a position in Lucira Health, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Howe & Rusling's Lucira Health, Inc. Common Stock position peaked at $1K in Q2 2021.
  • 36 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2021.

Based on Howe & Rusling's 13F filing for Q3 2021, filed 15 Nov 2021.